Company intelligence / Profile preview

Cignpost Diagnostics

Godalming, Surrey, United Kingdomcignpost.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cignpost Diagnostics rapidly became a leading provider of COVID‑19 testing in the UK during the pandemic. It now offers a broader range of health diagnostics and consultancy services to industries requiring workforce safety and continuity. The company was notably the largest UK consumer travel sector COVID test provider via its ExpressTest brand.

No clinical trial results as it does not develop drugs or devices.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Non-pharmacological therapy
Industry: Molecular Diagnostics

Partnerships

NetflixBBCPGA European Tour/DP World Tour

Beyond the preview

Go deeper on Cignpost Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cignpost Diagnostics.

Explore the full profile